Last night fans were torn two ways as to who was telling the truth with the situation of DeLonge’s position with Blink 182. The initial statement from the band read:
“Matt Skiba of the Alkaline Trio will join Blink-182 in replacement of Tom DeLonge at the 8th annual Musink Music and Tattoo festival. “We were all set to play this festival and record a new album and Tom kept putting it off without reason. A week before we were scheduled to go in to the studio we got an email from his manager explaining that he didn’t want to participate in any Blink-182 projects indefinitely, but would rather work on his other non-musical endeavors.” Travis Barker and Mark Hoppus plan to honor all Blink-182 commitments including the Musink Festival and are excited to have singer/guitarist Matt Skiba join them for this project. “No hard feelings, but the show must go on for our fans.” Additionally, Skiba will continue to make new music and tour with the Alkaline Trio.”
Shortly after DeLonge released a statement of his own through social media.
“To all the fans, I never quit the band. I actually was on a phone call about a blink 182 event for New York City at the time all these weird press releases started coming in… Apparently those releases were ‘sanctioned’ from the band. Are we dysfunctional- yes. But, Christ….. #Awkward#BabyBackRibs“
Remaining Blink 182 members Barker and Hoppus spoke to Rolling Stone in an effort to clear things up. Barker said “I think he’s just bummed because Mark and I were finally honest. We always covered up for him before. It was always, “We’re going to record an album,” then “Tom refuses to get into the studio without a record deal.” So everyone does hella amounts of work to get a record deal and now Tom isn’t part of Blink-182.”
Hoppus also added “Travis and I are intent on protecting the legacy of Blink-182 and continue to do what we’ve been doing for the past two decades: continue playing the songs.”
Could Blink 182 have a new permanent guitarist? We shall have to wait and see where this story will lead.